Oxford Immunotec Global (Oxford Immunotec Global) Days Sales Outstanding : 36.49 (As of Sep. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Oxford Immunotec Global Days Sales Outstanding?

Oxford Immunotec Global's average Accounts Receivable for the three months ended in Sep. 2020 was $7.77 Mil. Oxford Immunotec Global's Revenue for the three months ended in Sep. 2020 was $19.44 Mil. Hence, Oxford Immunotec Global's Days Sales Outstanding for the three months ended in Sep. 2020 was 36.49.

The historical rank and industry rank for Oxford Immunotec Global's Days Sales Outstanding or its related term are showing as below:

OXFD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.04 Med: 55.99 Max: 78.07
Current: 74.67

During the past 9 years, Oxford Immunotec Global's highest Days Sales Outstanding was 78.07. The lowest was 38.04. And the median was 55.99.

OXFD's Days Sales Outstanding is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 69.24 vs OXFD: 74.67

Oxford Immunotec Global's Days Sales Outstanding declined from Sep. 2019 (62.94) to Sep. 2020 (36.49).

Oxford Immunotec Global Days Sales Outstanding Historical Data

The historical data trend for Oxford Immunotec Global's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Immunotec Global Days Sales Outstanding Chart

Oxford Immunotec Global Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Days Sales Outstanding

Get a 7-Day Free Trial

40.35

78.93

64.31

46.36

56.52

Oxford Immunotec Global Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Days Sales Outstanding	Get a 7-Day Free Trial															62.94	73.46	88.26	140.10	36.49

Competitive Comparison of Oxford Immunotec Global's Days Sales Outstanding

For the Diagnostics & Research subindustry, Oxford Immunotec Global's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford Immunotec Global's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford Immunotec Global's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Oxford Immunotec Global's Days Sales Outstanding falls into.

Oxford Immunotec Global Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Oxford Immunotec Global's Days Sales Outstanding for the fiscal year that ended in Dec. 2019 is calculated as

	Days Sales Outstanding (A: Dec. 2019 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2018 )	+	Accounts Receivable (A: Dec. 2019 ))	/	count )	/	Revenue (A: Dec. 2019 )	*	Days in Period
=	( (9.158	+	13.669)	/	2 )	/	73.71	*	365
=	11.4135					/	73.71	*	365
=	56.52

Oxford Immunotec Global's Days Sales Outstanding for the quarter that ended in Sep. 2020 is calculated as:

	Days Sales Outstanding (Q: Sep. 2020 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2020 )	+	Accounts Receivable (A: Sep. 2020 ))	/	count )	/	Revenue (A: Sep. 2020 )	*	Days in Period
=	( (4.677	+	10.866)	/	2 )	/	19.436	*	365 / 4
=	7.7715					/	19.436	*	365 / 4
=	36.49

Oxford Immunotec Global (NAS:OXFD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Oxford Immunotec Global Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Oxford Immunotec Global's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Immunotec Global (Oxford Immunotec Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Oxford Immunotec Global PLC (NAS:OXFD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

143 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4SE

Website

http://www.oxfordimmunotec.com

Oxford Immunotec Global PLC is a diagnostic company. It is focused on developing and commercializing proprietary tests for the management of underserved immune regulated conditions. Its products include T-spot TB, T-spot-CMV, T-spot PRT,T-cell extend etc. The company's research and development activities focus on Chronic infections, Transplantation, Autoimmune and Inflammatory disease, Immune oncology.

Executives

Andrew Scott Walton	director	430 SOUTH SPRING STREET, BURLINGTON NC 27215
Mark R. Klausner	director	C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Patricia Randall	director	C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Richard A Sandberg	director	330 NEVEDA STREET, NEWTON MA 02460-1458
Patrick J Balthrop	director	C/O MAXCYTE, INC., 9713 KEY WEST AVENUE, SUITE 400, ROCKVILLE MD 20850
Herm Rosenman	director	OXFORD IMMUNOTEC GLOBAL PLC, 94C INNOVATION DRIVE, HILTON PARK, SAN DIEGO X0 OX14 4RZ
James R Tobin	director	C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Ronald Asbury Andrews	director	5791 VAN ALLEN WAY, CARLSBAD CA 92008
Peter Wrighton-smith	director, officer: Chief Executive Officer	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Mclaughlin Matthew T E	officer: Chief Financial Officer	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Stefan C Linn	officer: Chief Operating Officer	C/O OXFORD IMMUNOTEC GLOBAL 940 INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Janet Louise Kidd	officer: General Counsel	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE, MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RZ
Elizabeth M Keiley	officer: SVP & General Counsel	C/O ENTASIS THERAPEUTICS HOLDINGS INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451
Richard M. Altieri	officer: Chief Financial Officer	C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON X0 OX14 4RZ
Richard Wenstrup	officer: Chief Medical Officer	C/O OXFORD IMMUNOTEC GLOBAL, 94C INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE X0 OX14 4RZ